Capital International Investors
GOSS icon

Capital International Investors’s Gossamer Bio GOSS Stock Holding History

Capital International Investors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-217,388
Closed -$2.1M – 449
2020
Q4 		$2.1M Sell
217,388
-4,426,173
-95% -$43.6M ﹤0.01% 429
2020
Q3 		$57.6M Sell
4,643,561
-514,390
-10% -$6.82M 0.02% 312
2020
Q2 		$67.1M Buy
5,157,951
+1,882,100
+57% +$23.7M 0.02% 286
2020
Q1 		$33.3M Hold
3,275,851
– – 0.01% 291
2019
Q4 		$51.2M Hold
3,275,851
– – 0.02% 267
2019
Q3 		$55M Hold
3,275,851
– – 0.02% 262
2019
Q2 		$72.7M Hold
3,275,851
– – 0.03% 256
2019
Q1 		$71M Buy
+3,275,851
New +$68.3M 0.03% 250

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Capital International Investors's GOSS Position: Q1 2021 in Review

Capital International Investors sold out of Gossamer Bio (GOSS) in Q1 2021, closing a stake of 217,388 shares — an estimated $2.1M sold.

Capital International Investors first reported a position in GOSS in Q1 2019 and held it in 8 quarters. The position peaked at $72.7M in Q2 2019. 123 funds tracked by Wall St. Rank hold GOSS as of Q1 2021.

  • Capital International Investors reported no remaining Gossamer Bio position as of Q1 2021 after selling out during the quarter.
  • Capital International Investors sold 217,388 Gossamer Bio shares in Q1 2021, an estimated $2.1M.
  • Capital International Investors first reported a position in Gossamer Bio in Q1 2019 and held it in 8 quarters.
  • Capital International Investors's Gossamer Bio position peaked at $72.7M in Q2 2019.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2021.

Based on Capital International Investors's 13F filing for Q1 2021, filed 14 May 2021.